Correct use and ease-of-use of placebo ELLIPTA dry-powder inhaler in adult patients with chronic obstructive pulmonary disease.

PLoS One · 2022 · PMC9377593 · PMID 35969632

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a slight trendno p-value reported

However, among the ≥75 years age group, there was a slight trend towards a decrease in the proportion of patients demonstrating correct use of the placebo ELLIPTA DPI at study end and in the proportion finding its use “very easy” (Figs 3 and 4 ).

also in 4,078 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.